title: [Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir].
authors.affiliation: Servicio de Farmacia, Hospital Lluís Alcanyís de Xàtiva, Valencia.. pelufo_ana@gva.es.
authors.forename: Ana
authors.initials: A
authors.lastname: Pelufo-Pellicer
authors.affiliation: Servicio de Farmacia, Hospital Lluís Alcanyís de Xàtiva, Valencia.. lopez-montenegro_ang@gva.es.
authors.forename: MªÁngeles
authors.initials: M
authors.lastname: López-Montenegro Soria
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000150:complications / Q000188:drug therapy; D005260:Female; D015658:HIV Infections / Q000150:complications; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir / Q000627:therapeutic use*; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000188:drug therapy; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D019438:Ritonavir / Q000627:therapeutic use*; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use; D000099226:Dolutegravir
chemical_list: D019380:Anti-HIV Agents; D000925:Anticoagulants; D017320:HIV Protease Inhibitors; D006575:Heterocyclic Compounds, 3-Ring; D061466:Lopinavir; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D019438:Ritonavir; D014859:Warfarin; D000099226:Dolutegravir